Simultaneous targeting of MET overexpression in EGFR mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy?

Detalles Bibliográficos
Autores principales: Kanemura, Hiroaki, Takeda, Masayuki, Nakagawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481636/
https://www.ncbi.nlm.nih.gov/pubmed/32953535
http://dx.doi.org/10.21037/tlcr-20-707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481636/
https://www.ncbi.nlm.nih.gov/pubmed/32953535
http://dx.doi.org/10.21037/tlcr-20-707

Ejemplares similares